New concepts in breast cancer therapy

Internal Medicine Journal

Volumn 34, Issue 5, 2004, Pages 266-269

  Snyder, R D ^a  

^a St Vincent's Health ^*  (Australia)

Author keywords

Antineoplastic agents; Breast neoplasm; Chemoprevention; Hormone therapy

Indexed keywords

ALPHA TOCOPHEROL; ANASTROZOLE; ANTINEOPLASTIC AGENT; CAPECITABINE; CLONIDINE; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIDERMAL GROWTH FACTOR; ESTROGEN; FLUOROURACIL; FLUOXETINE; GEMCITABINE; LETROZOLE; METHOTREXATE; NAVELBINE; PACLITAXEL; PROTEIN TYROSINE KINASE; SEROTONIN 1 ANTAGONIST; SEROTONIN 2 ANTAGONIST; SEROTONIN UPTAKE INHIBITOR; TAMOXIFEN; TAXANE DERIVATIVE; TRASTUZUMAB; VENLAFAXINE;

ADJUVANT CHEMOTHERAPY; ANXIETY; BREAST CANCER; CANCER CHEMOTHERAPY; CLINICAL TRIAL; DEPRESSION; ENDOMETRIUM CANCER; GENE MUTATION; HOT FLUSH; HUMAN; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SIDE EFFECT; SOCIAL PSYCHOLOGY; SYMPTOMATOLOGY; THROMBOEMBOLISM;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, HORMONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; NEOPLASM STAGING; PROGNOSIS; TREATMENT OUTCOME;

EID: 2942536597     PISSN: 14440903     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1444-0903.2004.00586.x     Document Type: Review

References (18)

1. Australian Institute of Health and Welfare and Australasian Association of Cancer Registries. Cancer in Australia 1999 [Internet]. Canberra: Australian Institute of Health and Welfare and Australasian Association of Cancer Registries; 2002 [cited 22 August 2003]. Available from: URL: http://www.aihw.gov.au/ publications/can/ca99/ca99-c03.pdf
2. Carlson RW. Clinical implications of lymph node and bone marrow micrometastasis in breast cancer. In: Perry MC, ed. American Society of Clinical Oncology Education Book. Alexandria, USA: American Society of Clinical Oncology; 2003; 561-5.
3. Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG et al. AJCC Cancer Staging Manual, 6th edn. New York: Springer-Verlag; 2002.
4. Singletary SE, Alldred C, Ashley P, Bassett LW, Berry D, Bland KI et al. Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol 2002; 20: 3628-36.
5. Cuzick J, Powles T, Veronisi U, Forbes J, Edwards R, Ashley S et al. Overview of the main outcomes in breast-cancer prevention trials. Lancet 2003; 361: 296-300.
6. van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AAM, Voskuil DW et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 2002; 347: 1999-2009.
7. Goldhirsch A, Wood WC, Gelber RD, Coates AS, Thürlimann B, Senn HJ. Meeting highlights: Updated international expert consensus on the primary therapy of early breast cancer. J Clin Oncol 2003; 21: 3357-65.
8. International Breast Cancer Study Group (IBCSG). Adjuvant chemotherapy followed by goserelin versus either modality alone for premenopausal lymph node-negative breast cancer: a randomised trial. J Natl Cancer Inst 2003; 95: 1833-46.
9. The ATAC Trialists' Group. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial. Lancet 2002; 359: 2131-9.
10. Goss PE, Ingle JN, Martino S, Robert NJ, Muss HB, Piccart MJ et al. A randomized study of letrozole in postmenopausal women after five years tamoxifen therapy for early-stage breast cancer. N Engl J Med 2003; 349: 1793-802.
11. Smith IE. New drugs for breast cancer. Lancet 2002; 360: 790-92.
12. Slamon DJ, Leyland-Jones B, Shak S, Fuchs H, Paton V, Bajamonde A et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 2001; 344: 783-92.
13. iSource National Breast Cancer Centre. Clinical Practice Guidelines for the Management of Early Breast Cancer [Internet], 2nd edn. Canberra: National Health and Medical Research Council; 2001 [cited 22 August 2003]. Available from: URL: http://www.health.gov.au/nhmrc/publications/pdf/cp74.pdf
14. iSource National Breast Cancer Centre Advanced Breast Cancer Working Group. Clinical Practice Guidelines for the Management of Advanced Breast Cancer [Internet]. Canberra: National Health and Medical Research Council; 2001 [cited 22 August 2003]. Available from: URL: http://www.health.gov.au/nhmrc/ publications/pdf/cp76.pdf
15. National Health and Medical Research Council National Breast Cancer Centre Psychosocial Working Group. Psychosocial Clinical Practice Guidelines: Information, Support and Counselling for Women With Breast Cancer. [Internet]. Canberra: National Health and Medical Research Council; 2000 [cited 22 August 2003]. Available from: URL: http://www.health.gov.au/nhmrc/publications/pdf/ cp61.pdf
16. Stearns V, Ullmer L, Lo'pez JF, Smith Y, Isaacs C, Hayes DF. Hot flushes. Lancet 2002; 360: 1851-61.
17. Vogel CL. Adjuvant taxanes. In: Perry MC, ed. American Society of Clinical Oncology Education Book. Alexandria, USA: American Society of Clinical Oncology; 2003; 58-64.
18. Citron ML, Berry DA, Cirrincione C, Hudis C, Winer EP, Gradishar WJ et al. Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741. J Clin Oncol 2003; 21: 1431-9.